Liver metastases from cancer of unknown primary (CUPL): A retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature

Cancer Treatment Reviews

Volumn 34, Issue 8, 2008, Pages 693-700

  Lazaridis, George ^a,c   Pentheroudakis, George ^a,c   Fountzilas, George ^b,c   Pavlidis, Nicholas ^a,c  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c Hellenic Cooperative Oncology Group   (Greece)

Author keywords

Cancer of unknown primary; Chemotherapy; Liver metastases; Survival

Indexed keywords

CAPECITABINE; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PLATINUM COMPLEX;

ABDOMINAL SCINTISCANNING; ADULT; AGE DISTRIBUTION; AGED; ANEMIA; BLOOD TOXICITY; BONE METASTASIS; CANCER OF UNKNOWN PRIMARY SITE; CANCER RESISTANCE; CLINICAL FEATURE; CLINICAL TRIAL; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; EMBASE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL TOXICITY; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; LITERATURE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDLINE; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; THORAX SCINTISCANNING;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LOGISTIC MODELS; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56249146650     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2008.05.005     Document Type: Review

References (22)

1. Pavlidis N., and Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 54 3 (2005) 243-250
2. Abbruzzese J.L., Abbruzzese M.C., Lenzi R., Hess K.R., and Raber M.N. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13 8 (1995) 2094-2103
3. Frost P., Raber M.N., and Abbruzzese J.L. Unknown primary tumors as unique clinical and biologic entity: a hypothesis. Cancer Bull 41 (1998) 139-141
4. Le C.T., Cvitkovic E., Caille P., Harvey J., Contesso G., Spielmann M., et al. Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 148 9 (1988) 2035-2039
5. Nystrom J.S., Weiner J.M., Heffelfinger-Juttner J., Irwin L.E., Bateman J.R., and Wolf R.M. Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 4 1 (1977) 53-58
6. Kolesnikov-Gauthier H., Levy E., Merlet P., Kirova J., Syrota A., Carpentier P., et al. FDG PET in patients with cancer of an unknown primary. Nucl Med Commun 26 12 (2005) 1059-1066
7. Mousseau M., Schaerer R., Lutz J.M., Menegoz F., Faure H., and Swiercz P. Hepatic metastasis of unknown primary site. Bull Cancer 78 8 (1991) 725-736
8. Pentheroudakis G., Briasoulis E., and Pavlidis N. Cancer of unknown primary site:missing primary or missing biology?. Oncologist 12 (2007) 418-425
9. Coates M., and Armstrong B. Cancer in New south Wales. Incidence and mortality (1995), Cancer Council, NSW
10. Komov D.V., Komarov I.G., and Podrguliskii K.R. Cancer metastases from an unestablished primary tumor (clinical aspects, diagnosis, treatment). Sov Med Rev F Oncol 4 (1991) 1-33
11. Levi F., Te V.C., Erler G., Randimbison L., and La Vechia C. Epidemiology of unknown primary tumors. Eur J Cancer 38 (2002) 1810-1812
12. Muir C. Cancer of unknown primary site. Cancer 75 (1995) 353-356
13. Parkin D.M., and Muir C.S. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 120 (1992) 45-173
14. Visser O., Coebergh J.W., and Schouten L.J. Incidence of cancer in the Netherlands (1993), The Netherlands Cancer Registry, Utrecht
15. Abbruzzese J.L., Abbruzzese M.C., Hess K.R., Raber M.N., Lenzi R., and Frost P. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12 6 (1994) 1272-1280
16. van der G.A., Verweij J., Planting A.S., Hop W.C., and Stoter G. Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site. J Clin Oncol 13 7 (1995) 1720-1725
17. Sporn J.R., and Greenberg B.R. Empirical chemotherapy for adenocarcinoma of unknown primary tumor site. Semin Oncol 20 3 (1993) 261-267
18. Ayoub J.P., Hess K.R., Abbruzzese M.C., Lenzi R., Raber M.N., and Abbruzzese J.L. Unknown primary tumors metastatic to liver. J Clin Oncol 16 6 (1998) 2105-2112
19. Hogan B.A., Thornton F.J., Brannigan M., Browne T.J., Pender S., O'Kelly P., et al. Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations. Clin Radiol 57 12 (2002) 1073-1077
20. Pouessel D., Thezenas S., Culine S., Becht C., Senesse P., and Ychou M. Hepatic metastases from carcinomas of unknown primary site. Gastroenterol Clin Biol 29 12 (2005) 1224-1232
21. Bishop J.F., Tracey E., Glass P., Jelfs P., and Roder D. Prognosis of sub-types of cancer of unknown primary (CUP) compared to metastatic cancer. J Clin Oncol 25 18 Suppl. (2007) 21010
22. Pentheroudakis G., and Pavlidis N. Perspectives for targeted therapies in cancer of unknown primary. Cancer Treat Rev 32 (2006) 637-644